MBL2 Blocking Peptide
Référence BP9821a
Conditionnement : 500ug
Marque : Abcepta
MBL2 Blocking Peptide
Synthetic peptide
| Primary Accession | P11226 |
|---|
| Gene ID | 4153 |
|---|---|
| Other Names | Mannose-binding protein C, MBP-C, Collectin-1, MBP1, Mannan-binding protein, Mannose-binding lectin, MBL2, COLEC1, MBL |
| Target/Specificity | The synthetic peptide sequence is selected from aa 210-221 of HUMAN MBL2 |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
| Name | MBL2 (HGNC:6922) |
|---|---|
| Function | Calcium-dependent lectin, which acts as a pattern recognition receptor that initiates the lectin pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:14515269, PubMed:22966085, PubMed:7634089, PubMed:9087411). Specifically recognizes and binds the mannose moiety of carbohydrates on the pathogen surface, activating the MASP1 serine protease and initiating the proteolytic cascade of the lectin complement pathway (PubMed:22966085, PubMed:2573758, PubMed:6643429, PubMed:8082295, PubMed:9087411). Upon SARS coronavirus-2/SARS-CoV-2 infection, activates the complement lectin pathway which leads to the inhibition SARS-CoV-2 infection and a reduction of the induced inflammatory response (PubMed:35102342). May bind DNA (PubMed:15145932). |
| Cellular Location | Secreted. Cell surface. Note=Specifically binds mannose moiety of carbohydrates on the surface of pathogens. |
| Tissue Location | Plasma protein produced mainly in the liver. |
Research Areas
- Peptides
- Blocking Peptides

